Stimuli-responsive biodegradable poly(methacrylic acid) based nanocapsules for ultrasound traced and triggered drug delivery system

Biomaterials

Volumn 35, Issue 6, 2014, Pages 2079-2088

  Yang, Peng ^a   Li, Dian ^a   Jin, Sha ^a   Ding, Jing ^b   Guo, Jia ^a   Shi, Weibin ^b   Wang, Changchun ^a  

^a FUDAN UNIVERSITY   (China)

^b XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biodegradable; Drug delivery; Imaging; Nanocapsule; Ultrasound pH GSH responsive

Indexed keywords

ACOUSTIC DROPLET VAPORIZATION; BIODEGRADABLE; DISULFIDE CROSS-LINKING; DRUG-LOADING EFFICIENCY; POLY (METHACRYLIC ACID); THERAPEUTIC APPLICATION; THERAPEUTIC FUNCTIONS; ULTRASOUND CONTRAST AGENT;

BUBBLES (IN FLUIDS); CROSSLINKING; DRUG DELIVERY; IMAGING TECHNIQUES; NANOCAPSULES; ULTRASONICS;

LOADING;

DOXORUBICIN; NANOCAPSULE; PERFLEXANE; POLYMETHACRYLIC ACID;

ACOUSTIC DROPLET VAPORIZATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CONTROLLED STUDY; CROSS LINKING; DRUG DELIVERY SYSTEM; DRUG RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULUS RESPONSE; ULTRASOUND; VAPORIZATION;

BIODEGRADABLE; DRUG DELIVERY; IMAGING; NANOCAPSULE; ULTRASOUND/PH/GSH RESPONSIVE;

ANIMALS; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FLUOROCARBONS; HELA CELLS; HUMANS; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; NANOCAPSULES; PANCREATIC NEOPLASMS; POLYMETHACRYLIC ACIDS; TOPOISOMERASE II INHIBITORS; ULTRASONICS;

EID: 84890130882     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.11.057     Document Type: Article

References (43)

1. Varmus H. The new era in cancer research. Science 2006, 312:1162-1165.
2. Minchinton A.I., Tannock I.F. Drug penetration in solid tumors. Nat Rev Cancer 2006, 6:583-592.
3. Schroeder A., Heller D.A., Winslow M.M., Dahlman J.E., Pratt G.W., Langer R., et al. Treating metastatic cancer with nanotechnology. Nat Rev Cancer 2012, 12:39-50.
4. Mitragotri S., Kost J. Low-frequency sonophoresis: a review. Adv Drug Deliv Rev 2004, 56:589-601.
5. Warden S.J., Fuchs R.K., Kessler C.K., Avin K.G., Cardinal R.E., Stewart R.L. Ultrasound produced by a conventional therapeutic ultrasound unit accelerates fracture repair. Phys Ther 2006, 86:1118-1127.
6. Deshpande N., Needles A., Willmann J.K. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010, 65:567-581.
7. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006, 60:324-330.
8. Lindner J.R. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov 2004, 3:527-532.
9. Qin S., Caskey C.F., Ferrara K.W. Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 2009, 54:R27-R57.
10. Gramiak R., Shah P.M. Echocardiography of the aortic root. Invest Radiol 1968, 3:356-366.
11. Schutt E.G., Klein D.H., Mattrey R.M., Riess J.G. Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals. Angew Chem Int Ed 2003, 42:3218-3235.
12. Quaia E., Calliada F., Bertolotto M., Rossi S., Garioni L., Rosa L., et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 2004, 232:420-430.
13. Hernot S., Unnikrishnan S., Du Z., Shevchenko T., Cosyns B., Broisat A., et al. Nanobody-coupled microbubbles as novel molecular tracer. JControl Release 2012, 158:346-353.
14. Pillai R., Marinelli E.R., Fan H., Nanjappan P., Song B., von Wronski M.A., et al. Aphospholipid-PEG2000-conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast enhanced ultrasound imaging of angiogenesis. Bioconjug Chem 2010, 21:556-562.
15. Xing Z., Wang J., Ke H., Zhao B., Yue X., Dai Z., et al. The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnology 2010, 21:145607.
16. Lin P.L., Eckersley R.J., Hall E.A.H. Ultrabubble: a laminated ultrasound contrast agent with narrow size range. Adv Mater 2009, 21:3949-3952.
17. Han L., Xiong P., Bai J.F., Che S.A. Spontaneous formation and characterization of silica mesoporous crystal spheres with reverse multiply twinned polyhedral hollows. JAm Chem Soc 2011, 133:6106-6109.
18. Bai M.Y., Cheng Y.J., Wickline S.A., Xia Y.N. Colloidal hollow spheres of conducting polymers with smooth surface and uniform, controllable sizes. Small 2009, 5:1747-1752.
19. Yang F., Li X.Y., Chen Z.P., Zhang Y., Wu J.R., Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agent of magnetic resonance and ultrasound imaging. Biomaterials 2009, 30:3882-3890.
20. Smith N.B., Lee S., Maione E., Roy R.B., McElligott S., Shung K.K. Ultrasound-mediated transdermal transport of insulin invitro through skin using novel transducer designs. Ultrasound Med Biol 2003, 29:311-317.
21. Dijkmans P.A., Juffermans L.J., Musters R.J., van Wamel A., ten Catec F.J., van Gilstd W., et al. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 2004, 5:245-246.
22. Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005, 4:255-260.
23. Liu Y., Miyoshi H., Nakamura M. Encapsulated ultrasound microbubbles: therapeutic application in drug/gene delivery. JControl Release 2006, 114:89-99.
24. Frenkel V. Ultrasound mediated delivery of drugs and genes to solid tumors. Adv Drug Deliv Rev 2008, 60:1193-1208.
25. Hernot S., Klibanov A.L. Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 2008, 60:1153-1166.
26. Geers B., Dewwite H., De Smedt S.C., Lentacker I. Crucial factors and emerging concepts in ultrasound-triggered drug delivery. JControl Release 2012, 164:248-255.
27. Wang C.H., Kang S.T., Yeh C.K. Superparamagnetic iron oxide and drug complex-embedded acoustic droplets for ultrasound targeted theranosis. Biomaterials 2013, 34:1852-1861.
28. Negishi Y., Hamano N., Tsunoda Y., Oda Y., Choijamts B., Endo-Takahashi Y., et al. AG73-modified bubble liposomes for targeted ultrasound imaging of tumor. Biomaterials 2013, 34:501-507.
29. Oeffinger B.E., Wheatley M.A. Development and characterization of a nano-scale contrast agent. Ultrasonics 2004, 42:343-347.
30. Rapoport N., Gao Z., Kennedy A. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. JNatl Cancer Inst 2007, 99:1095-1106.
31. Hobbs S.K., Monsk W.L., Yuan F., Roberts W.G., Griffith L., Torchilin V.P., et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998, 95:4607-4612.
32. Wang X., Chen H.R., Chen Y., Ma M., Zhang K., Li F.Q., et al. Perfluorohexane-encapsulated mesoporous silica nanocapsules as enhancement agents for highly efficient high intensity focused ultrasound (HIFU). Adv Mater 2012, 24:785-791.
33. Nam K.H., Christensen D.A., Kennedy A.M., Rapoport N. Acoustic droplet vaporization, cavitation, and therapeutic properties of copolymers tabilized perfluorocarbon nanoemulsions. Am Inst Phys Conf Proc 2009, 1113:124-128.
34. Lin Y.S., Hurley K.R., Haynes C.L. Critical considerations in the biomedical use of mesoporous silica nanoparticles. JPhys Chem Lett 2012, 3:364-374.
35. Park J., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N. Biodegradable luminescent porous silicon nanoparticles for invivo applications. Nat Mater 2009, 8:331-336.
36. Chen W., Zhong P., Meng F.H., Cheng R., Deng C., Feijen J., et al. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. JControl Release 2013, 169:171-179.
37. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotechnol 2007, 25:1165-1170.
38. Poland C.A., Duffin R., Kinloch I., Maynard A., Wallace W.A.H., Seaton A., et al. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3:423-428.
39. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
40. Pan Y.J., Chen Y.Y., Wang D.R., Wei C., Guo J., Lu D.R., et al. Redox/pH dual stimuli-responsive biodegradable nanohydrogels with varying responses to dithiothreitol and glutathione for controlled drug release. Biomaterials 2012, 33:6570-6579.
41. Zeng X., Sun Y.X., Zhang X.Z., Zhuo R.X. Biotinylated disulfide containing PEI/avidin bioconjugate shows specific enhanced transfection efficiency in HepG2 cells. Org Biomol Chem 2009, 7:4201-4210.
42. Liong M., Lu J., Kovochich M., Xia T., Ruehm S.G., Nel A.E. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery. ACS Nano 2008, 2:889-896.
43. Maeda H., Wu J., Sawa T., Matsumura Y., Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. JControl Release 2000, 65:271-284.